The need for increased utilization of statins after occlusive stroke

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 16, Issue 3-4, 2011, Pages 364-367

  Hebert, Patricia R ^a   Evans, Denis ^b   Schneider, Wendy R ^a   Rodriquez Paz, Enrique ^a   Hennekens, Charles H ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

cholesterol; statins; stroke

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

CONFERENCE PAPER; DRUG UTILIZATION; EVIDENCE BASED PRACTICE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

CARDIOVASCULAR DISEASES; DRUG UTILIZATION; GUIDELINES AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; STROKE;

EID: 80051542024     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248410390368     Document Type: Conference Paper

References (16)

1. Department of Health and Human Services Centers for Disease Control and Prevention. Stroke Facts and Statistics. http://www.cdc.gov/Stroke/stroke-facts. htm; 2009. Accessed December 9, 2009.
2. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008 ; 39 (5). 1647-1652
3. Hebert PR, Pfeffer MA, Hennekens CH. Use of statins and aspirin to reduce risks of cardiovascular disease. J Cardiovasc Pharmacol Ther. 2002 ; 7 (2). 77-80 (Pubitemid 34627478)
4. Röther J, Alberts MJ, Touzé E, et al. Risk factor profile and management of cerebrovascular patients in the REACH registry. Cerebrovasc Dis. 2008 ; 25 (4). 366-374 (Pubitemid 351555862)
5. Hennekens CH, Sacks F, Tonkin A, et al. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analysis. Arch Intern Med. 2004 ; 164 (1). 40-44 (Pubitemid 38067387)
6. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010 ; 375 (9716). 735-742
7. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 ; 366 (9493). 1267-1278
8. Amarenco P, Bogousslavsky J, Callahan J, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 ; 355 (6). 549-559 (Pubitemid 44202151)
9. Amarenco P, Goldstein LB, Szarek M, et al. Effect of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 ; 38 (12). 3198-204 (Pubitemid 350175737)
10. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009 ; 8 (5). 453-463
11. Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcome trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006 ; 48 (3). 438-443
12. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for health-care professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counsel on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 ; 37: 577-617 (Pubitemid 43732031)
13. Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol. 2003 ; 92 (2). 152-160 (Pubitemid 36835963)
14. Hennekens CH, Schneider WR. The need for wider and appropriate utilization of statins and aspirin in treatment and prevention of cardiovascular disease. Expert Rev Cardiovasc Ther. 2008 ; 6 (1). 95-107
15. Ovbiagele B. Pessin Award Lecture 2008: lessons from the stroke PROTECT program. J Neurol Sci. 2008 ; 275 (1-2). 1-6
16. Schwamm LH, Fonarow GC, Reeves MJ, et al. Get with the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009 ; 119 (1). 107-115